Novo Nordisk
NVO
#19
Rank
โ‚น41.087 T
Marketcap
โ‚น9,045
Share price
-0.40%
Change (1 day)
8.66%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚น693.04 Billion

According to Novo Nordisk's latest financial reports the company's total debt is โ‚น693.04 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novo Nordisk - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚น332.96 B8.37%
2022-12-31โ‚น307.25 B1.76%
2021-12-31โ‚น301.94 B141.18%
2020-12-31โ‚น125.19 B161.19%
2019-12-31โ‚น47.93 B768.78%
2018-12-31โ‚น5.51 B-68.36%
2017-12-31โ‚น17.43 B691.39%
2016-12-31โ‚น2.20 B-78.91%
2015-12-31โ‚น10.44 B40.21%
2014-12-31โ‚น7.45 B203.07%
2013-12-31โ‚น2.45 B-49.34%
2012-12-31โ‚น4.85 B-38.25%
2011-12-31โ‚น7.86 B-55.8%
2010-12-31โ‚น17.78 B43.36%
2009-12-31โ‚น12.40 B-40.79%
2008-12-31โ‚น20.95 B99.81%
2007-12-31โ‚น10.48 B-11.82%
2006-12-31โ‚น11.89 B-37.99%
2005-12-31โ‚น19.17 B42.54%
2004-12-31โ‚น13.45 B0.86%
2003-12-31โ‚น13.34 B37.41%
2002-12-31โ‚น9.70 B-18.3%
2001-12-31โ‚น11.88 B-1.14%
2000-12-31โ‚น12.02 B-5.44%
1999-12-31โ‚น12.71 B-25.72%
1998-12-31โ‚น17.11 B-3.85%
1997-12-31โ‚น17.79 B47.65%
1996-12-31โ‚น12.05 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น5.794 T 736.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.625 T 278.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.336 T 525.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.148 T 209.97%๐Ÿ‡ซ๐Ÿ‡ท France